Provention Bio logo and child and doctor

Delaying a T1D Diagnosis? The FDA Considers Teplizumab

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/18400304/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_363_Final_Provention_Anhalt_FDA.mp3″ libsyn_item_id=”18400304″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /] The very first treatment to prevent type 1 diabetes for any length of time is in front of the FDA right now. Teplizumab has been show to prevent the onset of type 1 diabetes in people shown to be…